Clear Street LLC Acquires 12.8% Stake in Ernexa Therapeutics Inc. (ERNA)

Clear Street LLC has filed a Schedule 13G regarding its holdings in Ernexa Therapeutics Inc. (ERNA). As of the event date on May 5, 2026, Clear Street LLC reported beneficial ownership of 149,499 shares of common stock, representing a 12.8% ownership stake in the company. This filing marks a significant new position for the filer, as previous ownership was reported at 0.0%. The filing indicates that Clear Street LLC holds sole voting and dispositive power over the entirety of these shares. The reporting person is classified as a broker-dealer (BD) organized in New York. The issuer, Ernexa Therapeutics Inc., is headquartered in Cambridge, MA. This disclosure was triggered by the acquisition of shares exceeding the 5% threshold, requiring public reporting under Rule 13d-1(d) of the Securities Exchange Act of 1934. The filing was signed by John DiBacco, Head of Markets Trading at Clear Street LLC.